Targeting prostate cancer by new bispecific monocyte engager directed to prostate-specific membrane antigen
Gargi Das, J. Ptáček, Jana Campbell, Xintang Li, Barbora Havlínová, Satish Kumar Reddy Noonepalle, Alejandro Villagra, Cyril Bařinka, Zora Nováková
This paper describes the design and characterization of a bispecific monocyte engager targeting PSMA for prostate cancer immunotherapy, showing effective activation of monocytes and tumor cell elimination.
PLoS ONE · Mar 17, 2025Peer-reviewedBioengineering